Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction (Q42675157)
Jump to navigation
Jump to search
scientific article published on May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction |
scientific article published on May 2002 |
Statements
1 reference
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction (English)
1 reference
Harold E Lebovitz
1 reference
Margaret Kreider
1 reference
Martin I Freed
1 reference
1 May 2002
1 reference
1 reference
25
1 reference
5
1 reference
815-821
1 reference
Identifiers
1 reference
1 reference